Comorbidity of ketamine dependence with major depressive disorder increases the vulnerability to neuroaxonal pathology
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comorbidity of ketamine dependence with major depressive disorder increases the vulnerability to neuroaxonal pathology
Authors
Keywords
-
Journal
JOURNAL OF PSYCHIATRIC RESEARCH
Volume 158, Issue -, Pages 360-364
Publisher
Elsevier BV
Online
2023-01-10
DOI
10.1016/j.jpsychires.2023.01.009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma neurofilament light chain levels are associated with depressive and anxiety symptoms in Parkinson’s disease
- (2022) Weifang Yin et al. NEUROLOGICAL SCIENCES
- Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine (“Ecstasy”) induced cytoskeletal damage
- (2022) F. Bavato et al. JOURNAL OF NEURAL TRANSMISSION
- Neurofilament light chain as novel blood biomarker of disturbed neuroaxonal integrity in patients with ketamine dependence
- (2021) Yu-Li Liu et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Altered neuroaxonal integrity in schizophrenia and major depressive disorder assessed with neurofilament light chain in serum
- (2021) Francesco Bavato et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Neurofilament Light Chain Is a Novel Biomarker for Major Depression and Related Executive Dysfunction
- (2021) Mu-Hong Chen et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Neurofilament Light Chain Is a Promising Biomarker in Alcohol Dependence
- (2021) Yanfei Li et al. Frontiers in Psychiatry
- Serum neurofilament light levels in normal aging and their association with morphologic brain changes
- (2020) Michael Khalil et al. Nature Communications
- Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant
- (2020) Saurabh S. Kokane et al. BEHAVIOURAL BRAIN RESEARCH
- Association of serum biomarker neurofilament light concentration with post-stroke depression: A preliminary study
- (2020) Hongling Zhao et al. GENERAL HOSPITAL PSYCHIATRY
- The relationship between lifestyle and serum neurofilament light protein in Huntington’s disease
- (2020) Travis Cruickshank et al. Brain and Behavior
- New psychoactive substances in Taiwan: challenges and strategies
- (2020) Ling-Yi Feng et al. CURRENT OPINION IN PSYCHIATRY
- Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia
- (2019) MHD Rami Al Shweiki et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Defining cognitive profiles of depressive patients using the Brief Assessment of Cognition in Affective Disorders
- (2019) Ruei-An Chen et al. PeerJ
- Chronic ketamine abuse is associated with orexin-A reduction and ACTH elevation
- (2019) Ming-Chyi Huang et al. PSYCHOPHARMACOLOGY
- Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders
- (2019) Kasper Katisko et al. JOURNAL OF NEUROLOGY
- Cognitive profile of ketamine-dependent patients compared with methamphetamine-dependent patients and healthy controls
- (2018) Liang-Jen Wang et al. PSYCHOPHARMACOLOGY
- Similar psychotic and cognitive profile between ketamine dependence with persistent psychosis and schizophrenia
- (2018) Wan-Ju Cheng et al. SCHIZOPHRENIA RESEARCH
- Dysfunctional cognitions of depressive inpatients and their relationship with treatment outcome
- (2015) Stephan Köhler et al. COMPREHENSIVE PSYCHIATRY
- Relationship Between Cognitive Impairment and Depressive Symptoms in Current Ketamine Users
- (2015) W. K. Tang et al. Journal of Studies on Alcohol and Drugs
- The serotonin–BDNF duo: Developmental implications for the vulnerability to psychopathology
- (2014) Judith Regina Homberg et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Neurobehavioral Pharmacology of Ketamine: Implications for Drug Abuse, Addiction, and Psychiatric Disorders
- (2013) K. A. Trujillo et al. ILAR JOURNAL
- Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression
- (2013) C. N. Haile et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Abnormalities in White Matter Microstructure Associated with Chronic Ketamine Use
- (2013) R Edward Roberts et al. NEUROPSYCHOPHARMACOLOGY
- Brain damages in ketamine addicts as revealed by magnetic resonance imaging
- (2013) Chunmei Wang et al. Frontiers in Neuroanatomy
- Neurodegeneration, β-amyloid and mood disorders: state of the art and future perspectives
- (2012) Armando Piccinni et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Ketamine use: a review
- (2011) Celia J. A. Morgan et al. ADDICTION
- Reduced Dorsal Prefrontal Gray Matter After Chronic Ketamine Use
- (2010) Yanhui Liao et al. BIOLOGICAL PSYCHIATRY
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
- (2009) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now